Nerium Biotechnology Applies To Cease Being A Reporting Issuer

SAN ANTONIO, TEXAS--(Marketwired - Feb. 25, 2014) - Nerium Biotechnology, Inc. ("the Company") wishes to announce that it has made application to the Ontario Securities Commission (the "Commission"), seeking a ruling pursuant to subsection 1(10)(a)(ii) of the Securities Act (Ontario) (the "Act") that it is not a reporting issuer. The Applicant is a reporting issuer only in Ontario and is not, and has never been, listed for trading on any stock exchange or quotation system, nor does it currently have any intention to do so. The Applicant has less than fifteen (15) beneficial security holders in the province of Ontario, and all have consented, in writing to the Company ceasing to be a reporting issuer in Ontario. Virtually all of the Company's operations are located in the United States and Central America, as are the vast majority of its shareholders.

Help employers find you! Check out all the jobs and post your resume.